Tennessee Community Ventures
VC Fund
Nashville, United States
Tennessee Community Ventures is a venture firm based in Tennessee.
- Total investments:
- 10
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Tennessee Community Ventures invests in
Social MediaVideoMobileCookingDiabetes
Stages Tennessee Community Ventures invests in
SeedSeries ASeries CFunding Round
Countries Tennessee Community Ventures invests in
United States
Round sizes
Seed $100k–$2.1MSeries A $630k–$3.5M
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
4 more contacts available
Round size
- Seed
- $100k–$2.1M
- Series A
- $630k–$3.5M
Investment Focus
Industry
- Social Media 2 (20%)
- Video 1 (10%)
- Mobile 1 (10%)
- Cooking 1 (10%)
- Diabetes 1 (10%)
Stage
- Seed 3 (30%)
- Series A 2 (20%)
- Series C 1 (10%)
- Funding Round 1 (10%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
William Guttman
General Partner
|
General Partner | Total investments: 28 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Overdog
|
Overdog is a social matchmaking platform connecting like-minded gamers to create better online multiplayer experiences. The company connects athletes and fans through their shared love of gaming through their easy and exciting mobile app. | $2.4M / Jul 17, 2015 | |
Nusirt
|
NuSirt Sciences is a biotechnology company focused on developing products targeting metabolic diseases associated with over-nutrition such as obesity, diabetes, and inflammatory stress. The company has developed a breakthrough technology platform that combines natural compounds with various pharmaceutical agents.NuSirts first product, NS-0100,uses NuSirts platform technology to combine the natural product leucine with a very low dose of metformin for the treatment of type II diabetes. Although, metformin is the gold standard in the treatment of early-type II diabetes many patients can not tolerate the adverse gastrointestinal side effects metformin can cause in some patients. The company is currently testing varying doses of NS-0100 in Phase 2 clinical study to find the most efficacious dose of this new combination. If NuSirts clinical trials are successful NS-0100 may offer patients a viable alternative to metformin. NuSirt has filed eleven patent applications (two of which have been issued) and completed four clinical and numerous pre-clinical studies based on the patented technologies. | $6M / Series C / May 13, 2015 | |
|
Nusirt
|
NuSirt Sciences is a biotechnology company focused on developing products targeting metabolic diseases associated with over-nutrition such as obesity, diabetes, and inflammatory stress. The company has developed a breakthrough technology platform that combines natural compounds with various pharmaceutical agents.NuSirts first product, NS-0100,uses NuSirts platform technology to combine the natural product leucine with a very low dose of metformin for the treatment of type II diabetes. Although, metformin is the gold standard in the treatment of early-type II diabetes many patients can not tolerate the adverse gastrointestinal side effects metformin can cause in some patients. The company is currently testing varying doses of NS-0100 in Phase 2 clinical study to find the most efficacious dose of this new combination. If NuSirts clinical trials are successful NS-0100 may offer patients a viable alternative to metformin. NuSirt has filed eleven patent applications (two of which have been issued) and completed four clinical and numerous pre-clinical studies based on the patented technologies. | $3.5M / Series A / Mar 01, 2014 | |
Streamweaver
|
Streamweaver is a software company located in Nashville, Tenn. The company's first product is a multi-angle mobile video app that automatically connects people to record together and then generates split-screen video. | $630K / Series A / Sep 01, 2013 | |
|
Overdog
|
Overdog is a social matchmaking platform connecting like-minded gamers to create better online multiplayer experiences. The company connects athletes and fans through their shared love of gaming through their easy and exciting mobile app. | $100K / Seed / Sep 01, 2013 | |
American Hometown Media
|
American Hometown Media (AHM) is a new company with roots stemming from analog publishing. Based in Franklin, Tenn., AHM utilizes similar DNA as traditional media companies such as Publishing Group of America (PGOA) and American Hometown Publishing (AHP), all of which were conceived and founded by Dan Hammond. Now, these roots have beentransferred to the digital world with AHM, establishing an internet platform to feature everyday American home cooks as the celebrity. Putting the spotlight on these unsung heroes is the "secret sauce" that is propelling this new digital offering. Although a technology company, AHM hasn't abandoned its analog roots. Utilizing its newspaper & magazine lineage, AHM is also a large syndicator of editorial content featuring journalism celebrating hometown cooks to community newspapers, magazines and other media around the country. Currently some two million households receive the AHM syndicated columns weekly. | $1.2M / Seed / Mar 01, 2013 | |
|
Nusirt
|
NuSirt Sciences is a biotechnology company focused on developing products targeting metabolic diseases associated with over-nutrition such as obesity, diabetes, and inflammatory stress. The company has developed a breakthrough technology platform that combines natural compounds with various pharmaceutical agents.NuSirts first product, NS-0100,uses NuSirts platform technology to combine the natural product leucine with a very low dose of metformin for the treatment of type II diabetes. Although, metformin is the gold standard in the treatment of early-type II diabetes many patients can not tolerate the adverse gastrointestinal side effects metformin can cause in some patients. The company is currently testing varying doses of NS-0100 in Phase 2 clinical study to find the most efficacious dose of this new combination. If NuSirts clinical trials are successful NS-0100 may offer patients a viable alternative to metformin. NuSirt has filed eleven patent applications (two of which have been issued) and completed four clinical and numerous pre-clinical studies based on the patented technologies. | $2.1M / Seed / Sep 01, 2012 | |
|
Overdog
|
Overdog is a social matchmaking platform connecting like-minded gamers to create better online multiplayer experiences. The company connects athletes and fans through their shared love of gaming through their easy and exciting mobile app. | $450K / Seed / Sep 01, 2012 | |
|
Nusirt
|
NuSirt Sciences is a biotechnology company focused on developing products targeting metabolic diseases associated with over-nutrition such as obesity, diabetes, and inflammatory stress. The company has developed a breakthrough technology platform that combines natural compounds with various pharmaceutical agents.NuSirts first product, NS-0100,uses NuSirts platform technology to combine the natural product leucine with a very low dose of metformin for the treatment of type II diabetes. Although, metformin is the gold standard in the treatment of early-type II diabetes many patients can not tolerate the adverse gastrointestinal side effects metformin can cause in some patients. The company is currently testing varying doses of NS-0100 in Phase 2 clinical study to find the most efficacious dose of this new combination. If NuSirts clinical trials are successful NS-0100 may offer patients a viable alternative to metformin. NuSirt has filed eleven patent applications (two of which have been issued) and completed four clinical and numerous pre-clinical studies based on the patented technologies. | $600K / Seed / Jun 01, 2012 | |
|
Overdog
|
Overdog is a social matchmaking platform connecting like-minded gamers to create better online multiplayer experiences. The company connects athletes and fans through their shared love of gaming through their easy and exciting mobile app. | $825.1K / Seed / Jun 01, 2012 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
SaaS Investors
99,274 investors
Enterprise Investors
77,348 investors
Health Care Investors
43,014 investors
Media (entertainment) Investors
29,128 investors
Gaming Investors
28,140 investors
Mobile Investors
12,672 investors
Social Media Investors
7,861 investors
SaaS VC Funds
61,208 investors
Enterprise VC Funds
49,693 investors
FAQ
What does Tennessee Community Ventures invest in?
Tennessee Community Ventures invests primarily in Social Media, Video and Mobile startups, most often at Seed and Series A stage. Most of the 10 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Tennessee Community Ventures's check size?
Tennessee Community Ventures typically joins rounds of $100k–$2.1M at Seed and $630k–$3.5M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Tennessee Community Ventures participates in.
How do I contact Tennessee Community Ventures?
Public channels for Tennessee Community Ventures include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Tennessee Community Ventures?
The team at Tennessee Community Ventures includes William Guttman (General Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
